Skip to main content
. Author manuscript; available in PMC: 2024 Jan 23.
Published in final edited form as: Drug Metab Rev. 2020 Jul 9;52(3):333–365. doi: 10.1080/03602532.2020.1772281

Figure 10.

Figure 10.

CYP4B1-mediated bioactivation vs. ω-hydroxylation of N-alkyl-3-furancarboxamides. (A) Bioactivation of N-pentyl-3-furancarboxamide (C5) to form GSH/NAL-trapped C5-adducts, and (B) ω-hydroxylation of N-octyl-3-furancarboxamide (C8) (Kowlaski et al., 2019).